Song J, Fan L, Shi D, Lai X, Wang H, Liu W
BMC Med. 2024; 22(1):261.
PMID: 38915009
PMC: 11197319.
DOI: 10.1186/s12916-024-03440-w.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M
Biomolecules. 2023; 13(10).
PMID: 37892201
PMC: 10604821.
DOI: 10.3390/biom13101519.
Zhu J, Lian J, Wang X, Wang R, Pang X, Xu B
Front Pharmacol. 2023; 14:1185850.
PMID: 37441531
PMC: 10333497.
DOI: 10.3389/fphar.2023.1185850.
Lv L, Sun X, Liu B, Song J, Wu D, Gao Y
Clin Epidemiol. 2022; 14:771-778.
PMID: 35761866
PMC: 9233496.
DOI: 10.2147/CLEP.S367547.
Yang Z, Zheng Y, Wu Z, Wen Y, Wang G, Chen S
Cancer Med. 2021; 10(12):4054-4065.
PMID: 34041866
PMC: 8209558.
DOI: 10.1002/cam4.3937.
Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer.
Zhang N, Ning F, Guo R, Pei J, Qiao Y, Fan J
Front Oncol. 2020; 10:585083.
PMID: 33215031
PMC: 7670074.
DOI: 10.3389/fonc.2020.585083.
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank.
He M, Fang Z, Hang D, Wang F, Polychronidis G, Wang L
Int J Cancer. 2020; 148(8):1867-1878.
PMID: 33091956
PMC: 8244830.
DOI: 10.1002/ijc.33351.
Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection.
Zhang Q, Ma X, Xu Q, Qin J, Wang Y, Liu Q
Oncotarget. 2017; 8(41):71138-71146.
PMID: 29050349
PMC: 5642624.
DOI: 10.18632/oncotarget.11424.
Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.
Kuhn T, Sookthai D, Graf M, Schubel R, Freisling H, Johnson T
Br J Cancer. 2017; 117(10):1572-1579.
PMID: 28898231
PMC: 5680462.
DOI: 10.1038/bjc.2017.313.
Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab.
Artac M, Uysal M, Karaagac M, Korkmaz L, Er Z, Guler T
J Gastrointest Cancer. 2016; 48(2):176-180.
PMID: 27714653
DOI: 10.1007/s12029-016-9879-4.
Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.
Gao C, Fang L, Li J, Zhao H
World J Gastroenterol. 2016; 22(8):2576-84.
PMID: 26937145
PMC: 4768203.
DOI: 10.3748/wjg.v22.i8.2576.
Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer.
Sokolov M, Angelov K, Vasileva M, Atanasova M, Vlahova A, Todorov G
Onco Targets Ther. 2015; 8:2329-37.
PMID: 26366089
PMC: 4562718.
DOI: 10.2147/OTT.S82958.
Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies.
Kakourou A, Koutsioumpa C, Lopez D, Hoffman-Bolton J, Bradwin G, Rifai N
Cancer Causes Control. 2015; 26(10):1449-60.
PMID: 26220152
PMC: 4763881.
DOI: 10.1007/s10552-015-0641-1.
In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.
Molzer C, Pfleger B, Putz E, Rossmann A, Schwarz U, Wallner M
Exp Cell Res. 2012; 319(4):536-45.
PMID: 23246570
PMC: 3569715.
DOI: 10.1016/j.yexcr.2012.12.003.
Physiological antioxidative network of the bilirubin system in aging and age-related diseases.
Kim S, Park S
Front Pharmacol. 2012; 3:45.
PMID: 22457648
PMC: 3303147.
DOI: 10.3389/fphar.2012.00045.
Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
Prizment A, Anderson K, Visvanathan K, Folsom A
Cancer Epidemiol Biomarkers Prev. 2011; 20(2):297-307.
PMID: 21217085
PMC: 3169294.
DOI: 10.1158/1055-9965.EPI-10-1146.
